Karyopharm Therapeutics Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Rangwala Reshma | EVP & Chief Medical Officer | Sale | 6,789 | $1.17 | $7,943 | 342,931 | Apr 22, 2024 |
| Paulson Richard A. | President and CEO | Sale | 3,563 | $1.29 | $4,596 | 1,157,273 | Apr 4, 2024 |
| Paulson Richard A. | President and CEO | Sale | 3,573 | $1.30 | $4,645 | 1,160,836 | Mar 5, 2024 |
| Poulton Stuart | EVP, Chief Development Officer | Sale | 16,311 | $1.17 | $19,084 | 335,666 | Mar 1, 2024 |
| Mason Michael | EVP, CFO & Treasurer | Sale | 27,687 | $1.17 | $32,394 | 404,918 | Mar 1, 2024 |
| Paulson Richard A. | President and CEO | Sale | 80,470 | $1.17 | $94,150 | 1,183,783 | Mar 1, 2024 |
| Rangwala Reshma | EVP & Chief Medical Officer | Sale | 5,969 | $1.20 | $7,163 | 349,720 | Feb 29, 2024 |
| Mano Michael | SVP, General Counsel&Secretary | Sale | 3,576 | $1.20 | $4,291 | 277,852 | Feb 29, 2024 |
| Cheng Sohanya Roshan | EVP & Chief Commercial Officer | Sale | 5,109 | $1.20 | $6,131 | 393,509 | Feb 29, 2024 |
| Rangwala Reshma | EVP & Chief Medical Officer | Award / Grant | 198,959 | — | — | 371,356 | Feb 28, 2024 |
| Poulton Stuart | EVP, Chief Development Officer | Award / Grant | 188,205 | — | — | 351,977 | Feb 28, 2024 |
| Mano Michael | SVP, General Counsel&Secretary | Award / Grant | 147,000 | — | — | 298,401 | Feb 28, 2024 |
| Cheng Sohanya Roshan | EVP & Chief Commercial Officer | Award / Grant | 198,959 | — | — | 420,458 | Feb 28, 2024 |
| Paulson Richard A. | President and CEO | Award / Grant | 442,800 | — | — | 1,264,253 | Feb 28, 2024 |
| Mason Michael | EVP, CFO & Treasurer | Award / Grant | 188,205 | — | — | 432,605 | Feb 27, 2024 |
| Poulton Stuart | EVP, Chief Development Officer | Sale | 99 | $1.40 | $139 | 163,772 | Feb 15, 2024 |
| Mason Michael | EVP, CFO & Treasurer | Sale | 4,205 | $1.59 | $6,686 | 246,945 | Feb 6, 2024 |
| Paulson Richard A. | President and CEO | Sale | 4,012 | $1.59 | $6,379 | 821,453 | Feb 6, 2024 |
| Cheng Sohanya Roshan | EVP & Chief Commercial Officer | Award / Grant | 14,167 | — | — | 221,499 | Jan 24, 2024 |
| Rangwala Reshma | EVP & Chief Medical Officer | Award / Grant | 14,167 | — | — | 172,397 | Jan 24, 2024 |
| Poulton Stuart | EVP, Chief Development Officer | Award / Grant | 13,333 | — | — | 169,619 | Jan 24, 2024 |
| Mano Michael | SVP, General Counsel&Secretary | Award / Grant | 9,167 | — | — | 151,401 | Jan 24, 2024 |
| Mason Michael | EVP, CFO & Treasurer | Award / Grant | 13,333 | — | — | 251,150 | Jan 24, 2024 |
| Paulson Richard A. | President and CEO | Award / Grant | 42,000 | — | — | 825,465 | Jan 24, 2024 |
| Paulson Richard A. | President and CEO | Sale | 4,114 | $0.82 | $3,373 | 783,465 | Jan 4, 2024 |
| Paulson Richard A. | President and CEO | Sale | 3,622 | $0.79 | $2,861 | 787,579 | Dec 4, 2023 |
| Paulson Richard A. | President and CEO | Sale | 3,606 | $0.92 | $3,318 | 791,201 | Nov 6, 2023 |
| Paulson Richard A. | President and CEO | Sale | 3,589 | $1.27 | $4,558 | 794,807 | Oct 4, 2023 |
| BOHLIN GAREN G | — | Purchase | 41,140 | $1.22 | $50,191 | 45,140 | Sep 12, 2023 |
| Paulson Richard A. | President and CEO | Sale | 3,558 | $1.33 | $4,732 | 798,460 | Sep 5, 2023 |
| Mason Michael | EVP, CFO & Treasurer | Sale | 6,913 | $1.33 | $9,194 | 237,817 | Sep 1, 2023 |
| Mano Michael | SVP, General Counsel&Secretary | Sale | 3,888 | $1.33 | $5,171 | 142,234 | Sep 1, 2023 |
| Cheng Sohanya Roshan | EVP & Chief Commercial Officer | Sale | 7,415 | $1.33 | $9,862 | 204,086 | Sep 1, 2023 |
| Paulson Richard A. | President and CEO | Sale | 3,722 | $1.72 | $6,402 | 802,018 | Aug 7, 2023 |
| Poulton Stuart | EVP, Chief Development Officer | Sale | 2,845 | $1.70 | $4,837 | 156,286 | Jul 28, 2023 |
| Paulson Richard A. | President and CEO | Sale | 3,538 | $1.72 | $6,085 | 805,740 | Jul 5, 2023 |
| Cheng Sohanya Roshan | EVP & Chief Commercial Officer | Sale | 1,839 | $2.35 | $4,322 | 211,501 | Jun 8, 2023 |
| Paulson Richard A. | President and CEO | Sale | 3,536 | $2.24 | $7,921 | 809,278 | Jun 5, 2023 |
| Mason Michael | EVP, CFO & Treasurer | Sale | 631 | $2.22 | $1,401 | 244,730 | Jun 2, 2023 |
| Paulson Richard A. | President and CEO | Sale | 3,805 | $3.35 | $12,747 | 812,814 | May 4, 2023 |
| Rangwala Reshma | EVP & Chief Medical Officer | Sale | 6,655 | $4.05 | $26,953 | 158,230 | Apr 20, 2023 |
| Paulson Richard A. | President and CEO | Sale | 3,497 | $3.97 | $13,883 | 816,619 | Apr 4, 2023 |
| Paulson Richard A. | President and CEO | Sale | 3,506 | $3.16 | $11,079 | 820,116 | Mar 6, 2023 |
| Mitchener Stephen | SVP, Chief Business Officer | Award / Grant | 60,000 | — | — | 134,670 | Mar 1, 2023 |
| Cheng Sohanya Roshan | EVP & Chief Commercial Officer | Award / Grant | 100,000 | — | — | 221,926 | Mar 1, 2023 |
| Rangwala Reshma | EVP & Chief Medical Officer | Award / Grant | 100,000 | — | — | 165,000 | Feb 28, 2023 |
| Poulton Stuart | EVP, Chief Development Officer | Award / Grant | 95,000 | — | — | 159,131 | Feb 28, 2023 |
| Mano Michael | SVP, General Counsel&Secretary | Sale | 6,878 | $3.03 | $20,840 | 146,122 | Feb 28, 2023 |
| Mason Michael | EVP, CFO & Treasurer | Sale | 11,205 | $3.03 | $33,951 | 245,361 | Feb 28, 2023 |
| Paulson Richard A. | President and CEO | Sale | 33,033 | $3.03 | $100,090 | 823,622 | Feb 28, 2023 |